Adial Pharmaceuticals, Inc. Warrants and Rights Outstanding
Adial Pharmaceuticals, Inc. (ADIL) had Warrants and Rights Outstanding of $300.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-03-05
- 2025-12-31: Warrants and Rights Outstanding $300.00K.
- 2025-09-30: Warrants and Rights Outstanding $500.00K.
- 2025-06-30: Warrants and Rights Outstanding $500.00K.
- 2025-06-17: Warrants and Rights Outstanding $197.00K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-13 |
| 2025-06-17 | $197.00K 10-K · filed 2026-03-05 |
| 2020-06-11 | $2.12M 10-Q · filed 2020-11-13 |
| 2019-12-31 | $93.10K 10-K · filed 2020-03-20 |
| 2019-09-30 | $93.10K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $93.10K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $93.10K 10-Q · filed 2019-05-13 |
| 2019-01-31 | $65.13K 10-Q · filed 2020-08-13 |
| 2019-01-22 | $300.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |